deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT03164551

TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment (TICON)

A Phase IV, Single-blinded, Prospective, Randomized, Controlled, Multi-center Study to Compare the Clinical Outcomes of Genea Embryo Review Instrument Plus (GERI+) Time Lapse System With a Conventional Embryo Culture and Assessment System

Sponsor: Merck KGaA, Darmstadt, Germany

Conditions Infertility
Updated 24 times since 2017 Last updated: Nov 6, 2020 Started: Apr 16, 2018 Primary completion: Nov 20, 2019 Completion: Nov 20, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Participant enrollment has remained significantly behind plan despite increased site enrollment activity.

A PHASE4 clinical study on Infertility, this trial is terminated or withdrawn. The trial is conducted by Merck KGaA, Darmstadt, Germany and has accumulated 24 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~May 2020 · 4 months · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Aug 2020 · 2 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

24 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE4

Show 19 earlier versions
  1. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE4

  2. Aug 2020 — Nov 2020 [monthly]

    Terminated PHASE4

  3. Jun 2020 — Aug 2020 [monthly]

    Terminated PHASE4

  4. May 2020 — Jun 2020 [monthly]

    Terminated PHASE4

    Status: Active Not RecruitingTerminated

  5. Jan 2020 — May 2020 [monthly]

    Active Not Recruiting PHASE4

  6. Nov 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE4

    Status: RecruitingActive Not Recruiting

  7. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE4

  8. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE4

  9. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE4

  10. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE4

  11. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE4

  12. Apr 2019 — Jun 2019 [monthly]

    Recruiting PHASE4

  13. Mar 2019 — Apr 2019 [monthly]

    Recruiting PHASE4

  14. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE4

  15. Dec 2018 — Jan 2019 [monthly]

    Recruiting PHASE4

  16. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE4

  17. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE4

  18. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  19. Jun 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Merck KGaA, Darmstadt, Germany
Data source: Merck KGaA, Darmstadt, Germany

For direct contact, visit the study record on ClinicalTrials.gov .